CEM Corporation announced the formation of a new subsidiary headquartered in Tokyo with an additional office in Osaka, Japan. CEM Japan will be responsible for all sales, marketing, technical support and service of the Company’s entire line of laboratory instrumentation in Japan and selecte ... more
CEM acquires key assets of Intavis Bioanalytical Instruments
CEM Corporation announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, in-situ hybridization and particularly in the field of peptide synthesis.
The Intavis instrumentation provides unique robotic synthesis technology that is very complementary to CEM’s line of microwave peptide synthesizers. In particular, this includes small scale highly-parallel formats for making peptides either on resins or membranes, which allow for direct screening. In contrast, CEM’s peptide synthesis technology provides extremely rapid and efficient peptide production at larger scales. With this acquisition, customers will now benefit from a complete portfolio of peptide synthesis technology available through CEM’s large global support network.
“We are very pleased to be acquiring the Intavis line of instruments and unique robotic technology. Strategically, it will expand CEM’s capabilities to fully support the development of peptide based therapeutics from early stage lead identification to preclinical and cGMP commercialization. In addition, this technology creates new bioscience sample preparation opportunities for CEM.” said Michael J. Collins, President and CEO of CEM.
Dr. Steffen Huettner, CEO of Intavis commented “We are proud to work together with CEM. This agreement enables a great future for the Intavis technologies and opens our company to focus on new developments”
During the transition, which is expected to last 4 months, Intavis will continue to sell and support their products. After the transition period, CEM will manufacture the Intavis instruments at their global headquarters in Matthews, NC. CEM will also assume full responsibility for sales, support, and service for all existing Intavis customers using its global support system.
- peptide synthesis
CEM announced that its fourth US patent covering microwave-assisted peptide synthesis (US7,582,728) was issued on September 1, 2009. The patent contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synt ... more
CEM Corporation has won a 2009 Presidential Green Chemistry Challenge Award in the Greener Reaction Conditions category for its Sprint(TM) Rapid Protein Analyzer. The company accepted the award during a ceremony at the Carnegie Institute for Science (CIS) inWashington, DC. The award, prese ... more
Oracle allows you to determine the fat content even in unknown samples - without method development or cumbersome calibration more
The SMART 6 features two major innovations compared to CEM's previous SMART 5 system: the ability to accurately analyze both wet and dry samples and a significant reduction in sample drying times more
Totally redesigned with an impressive list of features and capabilities, MARS 6 was developed to make microwave sample preparation virtually effortless more
Process and laboratory staff in the food industry are increasingly pressed for time. The fat content of ever more samples must be determined fast and accurately. Until recently, there was no reliable method to determine the fat content in different foods in less than 30 seconds. One method ... more
The microwave digestion system MARS 6 iWave was developed to make microwave digestion and microwave sample preparation virtually effortless. Advances in ICP and ICP-MS systems demand a microwave digestion system capable of providing fast, complete digestions for lower detection limits in a ... more
The Phönix Black™ Muffle Furnaces enable companies in many diverse industries to improve their process control, allowing them to make rapid adjustments to reduce "out-of-specification" product. These systems can perform many high temperature applications up to 97% faster than traditional mu ... more
- 1Virtual screening for active substances against the coronavirus
- 2analytica 2020 is postponed
- 3Thermo Fisher Scientific to Acquire QIAGEN
- 4Smartphone lab finds coronavirus in saliva
- 5The digital laboratory live and tangible
- 6Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
- 7analytica 2020: Bioanalysis for personalized medicine
- 8Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- 9New membrane separates small organic molecules
- 10Innovative ways to battle Parkinson’s disease